StockData

Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.48−0.03 (-1.99%)

Close on Nov 16, 2026Market cap $833.74KP/E –Yield –

Universe Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Universe Pharmaceuticals's price to sales ratio was 0.0× on Nov 11, 2026, against 0.0× a year earlier. Over the last 5 years it ranged from 0.0× to 0.8×, with a median of 0.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.0×−0.0
2025Dec 31, 20250.0×+0.0
2024Dec 31, 20240.0×−0.0
2023Dec 29, 20230.0×−0.8
2022Dec 30, 20220.8×+0.0
2021Dec 31, 20210.7×–

More Universe Pharmaceuticals figures

See a number that looks wrong?